Literature DB >> 12618127

Increased mu-opioid receptor labeling is found on inner molecular layer terminals of the dentate gyrus following seizures.

P S Skyers1, S Einheber, J P Pierce, T A Milner.   

Abstract

The hippocampal formation is a brain region sensitive to seizure development, a phenomenon thought to be mediated in part by mu-opioid receptor (MOR) activation. Previous studies have found a delayed increase in MOR immunoreactivity (IR) in the inner molecular layer (IML) of the dentate gyrus after experimentally induced seizures. However, whether these increases in MOR-IR are restricted to certain cell types or cellular compartments (i.e., presynaptic, postsynaptic, or glial profiles) has not been determined. Thus, the present study examined which subcellular profiles demonstrate changes in MOR-IR after kainic acid (KA)-induced seizures. Light microscopic (LM) analysis demonstrated seizure-induced increases in MOR-IR at three points of the IML (dorsal blade, ventral blade, and crest) at three levels of section (septal, mid-septotemporal, and temporal). Electron microscopic analysis of the IML revealed that MOR-IR was present in the same types of cellular profiles in both control and KA-treated rats. However, a significant increase in the number of MOR-labeled terminal profiles was revealed in KA-treated rats compared to controls. Additionally, some MOR-labeled terminals in KA-treated rats possessed excitatory-type morphology and contained enkephalin or dynorphin, peptides found in mossy fiber terminals. These data suggest that most of the seizure-induced increases in MOR expression in the IML are associated with terminals originating from several different neuronal populations, including granule cells, and possibly, surviving GABAergic interneurons, septal cholinergic, and/or supramamillary projection neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618127     DOI: 10.1016/s0014-4886(02)00018-3

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

1.  Kainic acid down-regulates NOP receptor density and gene expression in human neuroblastoma SH-SY5Y cells.

Authors:  Rosalia Cannarsa; Daniela Landuzzi; Chiara Cavina; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

Review 2.  Signaling mechanisms of μ-opioid receptor (MOR) in the hippocampus: disinhibition versus astrocytic glutamate regulation.

Authors:  Min-Ho Nam; Woojin Won; Kyung-Seok Han; C Justin Lee
Journal:  Cell Mol Life Sci       Date:  2020-07-15       Impact factor: 9.261

3.  Accelerated kindling development in mu-opioid receptor deficient mice.

Authors:  G Grecksch; A Becker; H Schroeder; J Kraus; H Loh; V Höllt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-12       Impact factor: 3.000

4.  Stress differentially alters mu opioid receptor density and trafficking in parvalbumin-containing interneurons in the female and male rat hippocampus.

Authors:  Teresa A Milner; Suzanne R Burstein; Gina F Marrone; Sana Khalid; Andreina D Gonzalez; Tanya J Williams; Kathryn C Schierberl; Annelyn Torres-Reveron; Keith L Gonzales; Bruce S McEwen; Elizabeth M Waters
Journal:  Synapse       Date:  2013-07-17       Impact factor: 2.562

5.  Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphine.

Authors:  Alexandre Charlet; Arnaud H Muller; Alexis Laux; Véronique Kemmel; Annie Schweitzer; Jean-Christophe Deloulme; Denise Stuber; François Delalande; Enrica Bianchi; Alain Van Dorsselaer; Dominique Aunis; Annie Andrieux; Pierrick Poisbeau; Yannick Goumon
Journal:  Mol Pain       Date:  2010-12-20       Impact factor: 3.395

Review 6.  Septo-hippocampo-septal loop and memory formation.

Authors:  Fatemeh Khakpai; Mohammad Nasehi; Ali Haeri-Rohani; Akram Eidi; Mohammad Reza Zarrindast
Journal:  Basic Clin Neurosci       Date:  2013

Review 7.  The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.

Authors:  Johannes Burtscher; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2017-08-07       Impact factor: 5.639

8.  The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.

Authors:  Morgan L Sturgeon; Rachel Langton; Shaunik Sharma; Robert A Cornell; Joseph Glykys; Alexander G Bassuk
Journal:  Epilepsia Open       Date:  2021-06-09

9.  Reorganization of supramammillary-hippocampal pathways in the rat pilocarpine model of temporal lobe epilepsy: evidence for axon terminal sprouting.

Authors:  Rabia Soussi; Jean-Luc Boulland; Emilie Bassot; Hélène Bras; Patrice Coulon; Farrukh Abbas Chaudhry; Jon Storm-Mathisen; Lotfi Ferhat; Monique Esclapez
Journal:  Brain Struct Funct       Date:  2014-06-03       Impact factor: 3.270

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.